ML-93
ML-93 is an orally active SAE inhibitor, with an IC50 value of 0.4 μM. ML-93 inhibits the SUMOylation pathway in HCT116 cells. ML-93 shows robust antitumor activity in the HCT116 colorectal carcinoma xenograft model. ML-93 can be used for the study of colorectal cancer[1].
Product Specifications
CAS Number
1858275-91-8
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
CC1=C(C=C(S1)C(C2=CN=CN=C2N[C@@H]3C[C@@H]([C@H](C3)O)COS(N)(=O)=O)=O)[C@H]4C5=CC(Cl)=CC=C5CCO4
Molecular Formula
C25H27ClN4O6S2
Molecular Weight
579.09
References & Citations
[1]Langston SP, et al. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer. J Med Chem. 2021 Mar 11;64 (5) :2501-2520.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
150011 100 µg
BLNK (B Cell Linker Protein, B Cell Adapter Containing a SH2 Domain Protein, B Cell Adapter Containing a Src Homology 2 Domain Protein, Cytoplasmic Adapter Protein, Src Homology 2 Domain-containing Leukocyte Protein of 65kD, SLP-65, BASH, SLP65, MGC111051), discontinued. see B0397-01B discontinued
Sign In for Pricing
View Details 
PT_40769-01 5 µg
GRO-beta/MIP-2 Rat Recombinant (CXCL2) (GRO b Rat)
Sign In for Pricing
View Details PT_40769-02 20 µg
GRO-beta/MIP-2 Rat Recombinant (CXCL2) (GRO b Rat)
Sign In for Pricing
View Details PT_40769-03 1 mg
GRO-beta/MIP-2 Rat Recombinant (CXCL2) (GRO b Rat)
Sign In for Pricing
View Details